/* Pinterest verifcation tag */
December 6, 2022 | Education, Event, Research
The 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) took place in Amsterdam from 26th to 28th October, and was attended by Dr. John. Mottershead online. The programme included Scientific Sessions, Hot Topics and […]
August 9, 2022 | Education, Event, Research
Recording now available: https://www.msakl.org.nz/our-resources/webinars/latest-research-update/
July 26, 2022 | Life with MS, Progressive, Research
Multiple Sclerosis NZ is currently in the process of providing information to Pharmac regarding the high unmet need of those with Secondary Progressive MS. A new treatment, Siponimod (Mayzent), is currently under review and due to be assessed by PTAC […]
May 24, 2022 | Research
ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented […]